Germline Determinants of Toxicity and Efficacy in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 Autologous CAR T-Cell Therapy

被引：0
|
作者：
Strati, Paolo [1 ]
Brandt, Amanda [2 ]
Henderson, Jared [3 ]
Westin, Jason [1 ]
Nastoupil, Loretta J. [2 ]
Al Zaki, Ajlan [4 ]
Jallouk, Andrew P. [5 ]
Adkins, Sherry
Shpall, Elizabeth J. [6 ]
Kebriaei, Partow [6 ]
Ramdial, Jeremy [6 ]
Saini, Neeraj Y. [6 ]
Ahmed, Sairah [7 ]
Flowers, Christopher R. [1 ]
Neelapu, Sattva S. [1 ]
Hildebrandt, Michelle [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Lymphoma Myeloma, Houston, TX 77030 USA
[5] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma & Stem Cell Transplantat, Houston, TX 77030 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180744
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Gut Bacterial Diversity Associates with Efficacy of Anti-CD19 CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma
    Saini, Neeraj
    Chang, Chia-Chi
    Strati, Paolo
    Nastoupil, Loretta J.
    Westin, Jason
    Nair, Ranjit
    Fayad, Luis
    Ahmed, Sairah
    Lee, Hun Ju
    Iyer, Swaminathan P.
    Steiner, Raphael Eric
    Greenbaum, Uri
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Jain, Nitin
    Green, Michael R.
    Ajami, Nadim J.
    Flowers, Christopher
    Champlin, Richard E.
    Wargo, Jennifer
    Neelapu, Sattva S.
    Jenq, Robert R.
    BLOOD, 2020, 136
  • [2] Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma
    Abramson, Jeremy S.
    TRANSFUSION MEDICINE REVIEWS, 2020, 34 (01) : 29 - 33
  • [3] Pre-Treatment Pulmonary Assessment Have Limited Utility in B-Cell Lymphoma Patients Treated with Autologous Anti-CD19 CAR T-Cell Therapy
    Sdayoor, Inbal
    Shouval, Roni
    Fried, Shalev
    Marcus, Ronit
    Danylesko, Ivetta
    Yerushalmi, Ronit
    Shem-Tov, Noga
    Itzhaki, Orit
    Jacoby, Elad
    Kedmi, Meirav
    Nagler, Arnon
    Shimoni, Avichai
    Segel, Michael J.
    Avigdor, Abraham
    BLOOD, 2023, 142
  • [4] Overcoming resistance to anti-CD19 CAR T-cell therapy in B-cell malignancies
    Yang, Xingcheng
    Wei, Jia
    Zhou, Jianfeng
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 821 - 834
  • [5] HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
    Bourbon, Estelle
    Sesques, Pierre
    Gossez, Morgane
    Tordo, Jeremie
    Ferrant, Emmanuelle
    Safar, Violaine
    Wallet, Florent
    Aussedat, Guillaume
    Maarek, Alizee
    Boua, Fadhela
    Karlin, Lionel
    Ghergus, Dana
    Golfier, Camille
    Lequeu, Helene
    Lazareth, Anne
    Schwiertz, Verane
    Viel, Sebastien
    Idlhaj, Maryam
    Ghesquieres, Herve
    Monneret, Guillaume
    Bachy, Emmanuel
    Venet, Fabienne
    BLOOD ADVANCES, 2023, 7 (05) : 744 - 755
  • [6] Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
    Chow, Victor A.
    Shadman, Mazyar
    Gopal, Ajay K.
    BLOOD, 2018, 132 (08) : 777 - 781
  • [7] Anti-CD19 CAR T Therapy Following Autologous HSCT May be Safe and Effective in Patients with Refractory Large B-Cell Lymphoma
    Liu, Wei
    Huang, Wenyang
    Lv, Rui
    Deng, Shuhui
    Yi, Shuhua
    Qiu, Lugui
    Zou, Dehui
    BLOOD, 2019, 134
  • [8] Outcomes and Treatment Patterns in Patients with Aggressive B-Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy
    Zurko, Joanna C.
    Epperla, Narendranath
    Nizamuddin, Imran
    Torka, Pallawi
    David, Kevin A.
    Ollila, Thomas A.
    Hess, Brian T.
    Cohen, Jonathon B.
    Ferdman, Robert
    Liu, Jieqi
    Chowdhury, Sayan Mullick
    O'Shea, Kaitlyn
    Romancik, Jason
    Bhansali, Rahul
    Harris, Elyse
    Sorrell, Mckenzie
    Masel, Rebecca
    Fitzgerald, Lindsey
    Galvez, Carlos
    Ma, Shuo
    Winter, Jane N.
    Pro, Barbara
    Gordon, Leo I.
    Danilov, Alexey V.
    Stephens, Deborah M.
    Shah, Nirav N.
    Shouse, Geoffrey
    Kenkre, Vaishalee P.
    Barta, Stefan K.
    Karmali, Reem
    BLOOD, 2021, 138
  • [9] A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off
    Leroy, Marie
    Deramoudt, Laure
    Pinturaud, Marine
    Demaret, Julie
    Alidjinou, Enagnon Kazali
    Nudel, Morgane
    Cavalieri, Doriane
    Chahla, Wadih Abou
    Odou, Pascal
    Morschhauser, Franck
    Yakoub-Agha, Ibrahim
    Simon, Nicolas
    Beauvais, David
    LEUKEMIA & LYMPHOMA, 2024, 65 (06) : 868 - 871
  • [10] Pharmacodynamic Profile and Clinical Response in Patients with B-Cell Malignancies of Anti-CD19 CAR T-Cell Therapy
    Perez, Arianne
    Navale, Lynn
    Rossi, John M.
    Shen, Yueh-wei
    Jiang, Yizhou
    Sherman, Marika
    Mardiros, Armen
    Yoder, Sean C.
    Go, William Y.
    Rosenberg, Steven A.
    Wiezorek, Jeff
    Roberts, Margo R.
    Chang, David D.
    Kochenderfer, James N.
    Bot, Adrian
    BLOOD, 2015, 126 (23)
12345